MYH11 anticorps

N° du produit ABIN7881731

Cet anticorps anti-MYH11 Monoclonal Souris (Clone SM-M10) (ABIN7881731) détecte spécifiquement MYH11 dans IF, IHC (p) et FACS. L’anticorps est réactif avec des échantillons de Humain.

Aperçu rapide pour MYH11 anticorps (ABIN7881731)

Antigène: MYH11 (Myosin Heavy Chain 11, Smooth Muscle (MYH11))

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp MYH11 est non-conjugé

Application: Immunofluorescence (IF), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Flow Cytometry (FACS)

Classe de qualité: Carrier-free

Clone: SM-M10

Détail du produit anti-MYH11 anticorps

Fonction: SMMHC Antibody / MYH11 (azide and preservative free)

Purification: Protein A/G affinity

Immunogène: Crude human uterus extract was used as the immunogen for the SMMHC antibody.

Isotype: IgG1, kappa

Information d'application

Indications d'application: Optimal dilution of the SMMHC antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: -20 °C

Stockage commentaire: Aliquot the SMMHC antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.

Détails sur MYH11

Antigène: MYH11 (Myosin Heavy Chain 11, Smooth Muscle (MYH11))

Autre désignation: SMMHC

Sujet: Smooth muscle myosin heavy chain (SM-MHC) is a cytoplasmic structural protein, which is a major component of the contractile apparatus in smooth muscle cells. Expression of smooth muscle myosin is developmentally regulated, appearing early in smooth muscle development, and is specific for smooth muscle development. Two isoforms of smooth muscle myosin heavy chain have been identified, designated MHC-1 and MHC-2. The antibody may be useful for the study of breast tumors as the presence of an intact layer of myoepithelial cells is an important feature, which may distinguish benign breast lesions and carcinoma in situ from invasive tumors.

UniProt: P35749